Skip to main content
. 2015 May 3;123(2):277–282. doi: 10.1007/s11060-015-1795-0

Fig. 1.

Fig. 1

MRI demonstrating a durable response. The patient had a biopsy and treatment of GB anterior and caudal to this lesion. The enhancing area in A appeared and progressed while the patient was receiving BEV, almost a year and a half after first line therapy. The response occurred slowly, over months, while the patient was receiving EP. a T1-post contrast at time of progression on BEV, b T1-post contrast at approximately 45 weeks on EP